Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BMRN
#850
BioMarin Pharmaceutical Inc. - Common Stock
58.6
9
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.09%
Monthly Change
+5.46%
6 month change
+6.71%
Year Change
+3.07%
Previous Close
58.6
4
Open
58.9
0
Low
58.6
8
High
59.0
0
Volume
116
Markets
US Stock Market
Healthcare
Biotechnology
BMRN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
191.78 M
192.01 M
192.11 M
192.32 M
193.28 M
193.28 M
Valuation ratios
Enterprise value
13.1 B
9.94 B
9.75 B
10.72 B
8.7 B
9.35 B
Price to earnings ratio
26.18
16.26
20.28
33.02
40.64
43.08
Price to sales ratio
4.73
3.53
3.44
3.64
3.42
3.62
Price to cash flow ratio
19.91
14.1
11.66
14.17
12.61
13.36
Price to book ratio
0.63
0.47
0.45
1.93
0.45
0.48
Enterprise value to EBITDA ratio
18.44
11.56
13.97
21.91
22.35
24.03
Profitability ratios
Return on assets %
0.03
0.03
-0
-0.01
0.01
0.01
Return on equity %
0.03
0.04
-0.01
-0.01
0.02
0.02
Return on invested capital %
13.32
16.75
-4.09
-5.77
7.14
7.14
Gross margin %
79.66
81.82
81.95
68.47
74.55
74.55
Operating margin %
30.05
33.55
-6.02
-5.1
16.92
16.92
EBITDA margin %
33.01
35.79
-3.63
-2.76
19.06
19.06
Net margin %
24.92
29.14
-3.96
-5.33
13.77
13.77
Liquidity ratios
Quick ratio
3.49
3.6
3.1
3.5
4.2
4.2
Current ratio
5.52
5.56
4.83
5.21
5.81
5.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.11
0.11
0.1
0.12
0.09
0.09
Solvency ratios
Debt to assets ratio
0.08
0.08
0.08
0.08
—
—
Debt to equity ratio
0.1
0.1
0.1
0.1
—
—
Long term debt to total assets ratio
0.08
0.08
0.08
0.08
0.17
0.17
Long term debt to total equity ratio
0.1
0.1
0.1
0.1
0.23
0.23
Per share metrics
Operating cash flow per share
0.89
0.94
1.92
0.5
1.12
4.48
EBIT per share
1.14
1.4
-0.24
-0.23
0.66
1.59
EBITDA per share
1.25
1.5
-0.15
-0.12
0.74
1.97
Total debt per share
3.03
3.02
3.11
3.03
—
—
Cash per share
6.48
7.27
7.7
7.91
11.24
11.24
Net current asset value per share
17.65
19.31
20.07
20.03
23.3
23.3
Tangible book value per share
29.49
30.58
31.54
30.84
31.43
31.43
Working capital per share
14.45
15.84
15.91
16.18
19.28
19.28
Book value per share
29.49
30.58
31.54
30.84
31.43
31.43
News
FDA Accepts BMRN's sNDA Seeking Full Approval for Voxzogo
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts
Ascendis Pharma Stock: Behind The Stock Surge (NASDAQ:ASND)
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised